66 results
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
24 Apr 24
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
Healthcare Conference
New York, NY
June 5 – 6
Stifel 2nd European Healthcare Summit Lyon
Lyon, France
June 25 - 27
First Quarter 2024 Financial
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
7 Feb 24
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:09pm
management will participate in the following upcoming investor event:
Oppenheimer 34th Annual Healthcare Life Sciences Conference
Virtual
February 13 – 14
8-K
EX-99.1
x16zmfcl1yu
25 Oct 23
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:24pm
PRE 14A
wqy6r8d1xq646
17 Apr 23
Preliminary proxy
5:04pm
424B5
ab2902ikg2xes op6
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
ut2q c5bqn49uhwidd
29 Mar 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
k64rpj13hy563ij j8
26 Oct 22
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-99.1
npexqh
27 Jul 22
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm